17:30:31 EDT Thu 12 Mar 2026
Enter Symbol
or Name
USA
CA



Contagious Gaming Inc (2)
Symbol CNS
Shares Issued 94,220,745
Recent Sedar+ Documents

Contagious still working on IMBiotechnologies RTO

2026-03-12 11:33 ET - News Release

Subject: News Release for Contagious Gaming PDF Document

File: Attachment 20260312 Contagious Gaming Inc. - PR - IMB RTO v.Final.pdf

CONTAGIOUS GAMING UPDATE ON TRANSACTION WITH IMBIOTECHNOLOGIES

NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES

VANCOUVER, B.C., March 12, 2026 Contagious Gaming Inc. (TSX-V: CNS) ("Contagious Gaming" or the "Company") is pleased to provide an update regarding the previously announced proposed combination with IMBiotechnologies Ltd. ("IMBiotechnologies").

As previously announced on July 17, 2024, the Company entered into a non-binding letter of intent with IMBiotechnologies pursuant to which the parties intend to complete a transaction that would constitute a reverse takeover of the Company (the "Transaction").

The Company and IMBiotechnologies continue to advance the Transaction and remain engaged in negotiations toward the execution of a definitive agreement. The parties are also continuing their respective due diligence investigations and working with advisors to determine the optimal legal structure for the Transaction.

In parallel with the Transaction, IMBiotechnologies continues to evaluate and advance plans for a concurrent financing, the proceeds of which are expected to be used to support commercialization activities and general corporate purposes.

The completion of the Transaction remains subject to a number of conditions, including but not limited to:

dot negotiation and execution of a definitive agreement;

dot completion of satisfactory due diligence by both parties;

dot completion of any required financing;

dot receipt of all required shareholder and regulatory approvals; and

dot satisfaction of other customary closing conditions.

There can be no assurance that the Transaction will be completed as proposed or at all.

Trading in the Company's common shares remains halted in accordance with the policies of the TSX Venture Exchange and is expected to remain halted until such time as the Exchange determines that trading may resume.

The Company will provide further updates as material developments occur. About Contagious Gaming

Contagious Gaming Inc. (TSX-V: CNS) is in the business of developing and investing software solutions for regulated gaming and lottery markets. The Company is focused on leveraging its existing assets for the B2B gaming marketplace.

For more information on Contagious Gaming please visit www.contagiousgaming.com.

For further information, please contact:

Craig Loverock, Chief Financial Officer

Email: craig.loverock@contagiousgaming.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This information release contains certain forward-looking information, including about the Offering, the receipt of all necessary regulatory approvals and the expected use of proceeds from the Offering. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

© 2026 Canjex Publishing Ltd. All rights reserved.